The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Diurizone Injectable

50, 0.5 milligram(s)/millilitre Solution for injection

Vetoquinol Ireland LimitedVPA10983/011/001

Main Information

Trade NameDiurizone Injectable
Active SubstancesHydrochlorothiazide
Strength50, 0.5 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderVetoquinol Ireland Limited
Licence NumberVPA10983/011/001

Group Information

ATC CodeQC03AX01 hydrochlorothiazide, combinations
Therapeutic ClassCardiovascular
Non food-producing horses


Licence Issued01/10/1989
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back